Nan Hu Selected Research

Nan Hu Research Topics

Disease

101	Neoplasms (Cancer) 05/2024 - 02/2002
29	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2003
17	Inflammation (Inflammations) 02/2024 - 01/2011
17	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2010
14	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
13	Stomach Neoplasms (Stomach Cancer) 11/2022 - 12/2009
12	Carcinogenesis 03/2024 - 07/2006
12	Fibrosis (Cirrhosis) 11/2023 - 04/2011
11	Infections 03/2024 - 06/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2012
10	Neoplasm Metastasis (Metastasis) 04/2024 - 10/2010
10	Obesity 09/2023 - 01/2013
9	Diabetes Mellitus 04/2024 - 03/2011
8	Rheumatoid Arthritis 04/2024 - 01/2017
7	Cognitive Dysfunction 12/2023 - 03/2014
7	Hypoxia (Hypoxemia) 01/2023 - 01/2012
7	Carcinoma (Carcinomatosis) 12/2022 - 02/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2011
6	Myocardial Infarction 01/2024 - 11/2017
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
6	Colitis 01/2021 - 05/2015
5	Osteoporosis 03/2024 - 05/2017
5	Thrombosis (Thrombus) 12/2023 - 09/2015
5	Ulcerative Colitis 01/2021 - 05/2015
5	Hypertension (High Blood Pressure) 01/2019 - 10/2012
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 02/2010
5	Adenocarcinoma 10/2017 - 10/2011
4	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 06/2013
4	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2016
4	Colonic Neoplasms (Colon Cancer) 11/2023 - 10/2016
4	Hyperglycemia 09/2023 - 01/2012
4	Insulin Resistance 09/2023 - 05/2014
4	Wounds and Injuries (Trauma) 01/2023 - 10/2009
4	Pain (Aches) 01/2023 - 10/2014
4	Edema (Dropsy) 11/2022 - 11/2017
4	Disease Progression 11/2022 - 03/2006
4	Hepatitis B 06/2022 - 04/2011
4	Hypertrophy 01/2022 - 04/2012
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2016
4	Ischemia 01/2022 - 02/2010
4	Cardiomegaly (Heart Hypertrophy) 12/2021 - 02/2013
4	Leukemia 01/2021 - 09/2009
4	Cicatrix (Scar) 01/2021 - 05/2014
4	Necrosis 11/2014 - 06/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 02/2017
3	Stroke (Strokes) 04/2024 - 01/2021
3	Bone Resorption 03/2024 - 01/2019
3	Chronic Renal Insufficiency 10/2023 - 07/2022

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2002
32	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2006
20	Messenger RNA (mRNA)IBA 02/2024 - 09/2004
16	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2003
13	RNA (Ribonucleic Acid)IBA 11/2023 - 09/2004
13	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2010
9	AntioxidantsIBA 02/2024 - 04/2011
7	CytokinesIBA 02/2024 - 07/2014
7	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 02/2010
7	Peptides (Polypeptides)IBA 08/2023 - 01/2010
7	EnzymesIBA 01/2022 - 02/2009
6	Adenosine Triphosphate (ATP)IBA 01/2024 - 12/2016
6	Dextran SulfateIBA 01/2021 - 05/2015
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2023 - 02/2009
5	ErbB Receptors (EGF Receptor)IBA 06/2022 - 01/2013
5	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2011
5	CollagenIBA 01/2022 - 01/2021
5	ORALIT (ORS)IBA 09/2021 - 04/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 06/2009
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 02/2017
4	Phosphotransferases (Kinase)IBA 01/2023 - 03/2013
4	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2014
4	Complement System Proteins (Complement)IBA 10/2022 - 08/2010
4	Mitochondrial Aldehyde DehydrogenaseIBA 01/2022 - 01/2012
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 06/2013
4	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 06/2013
4	Long Noncoding RNAIBA 10/2021 - 01/2018
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 01/2015
4	CholesterolIBA 10/2021 - 07/2012
4	Cytochrome P-450 CYP3AIBA 07/2021 - 03/2011
4	InterleukinsIBA 06/2021 - 06/2013
4	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2012
4	Antiviral Agents (Antivirals)IBA 01/2018 - 07/2004
4	GadoliniumIBA 01/2018 - 05/2014
3	NivolumabIBA 05/2024 - 03/2022
3	Hematoxylin (Haematoxylon)IBA 02/2024 - 04/2011
3	Therapeutic UsesIBA 02/2024 - 01/2022
3	Eosine Yellowish-(YS) (Eosin)IBA 02/2024 - 04/2011
3	Neuroprotective AgentsIBA 12/2023 - 02/2010
3	LipidsIBA 10/2023 - 10/2012
3	Nucleic AcidsIBA 08/2023 - 02/2014
3	Biocompatible Materials (Biomaterials)IBA 07/2023 - 10/2020

Therapy/Procedure

41	Therapeutics 04/2024 - 06/2009
21	Drug Therapy (Chemotherapy) 05/2024 - 06/2012
11	Radiotherapy 01/2022 - 01/2012
5	Lasers (Laser) 01/2013 - 02/2002
4	Transplantation 04/2024 - 04/2013
4	Oral Administration 12/2022 - 06/2012
4	Length of Stay 01/2022 - 12/2011
4	Chemoradiotherapy 01/2022 - 11/2017
3	Immunotherapy 11/2023 - 10/2019